Malondialdehyde Formation in Rat Platelet-Rich Plasma

Summary

Malondialdehyde (MDA) is a stable product of arachidonic acid metabolism, catalyzed by the enzyme cyclo-oxygenase. The experimental conditions for measuring the kinetics of MDA formation in rat citrated platelet-rich plasma were defined. Platelets were stimulated with either arachidonic acid, the substrate of MDA, or thrombin, an enzyme which induces release of free arachidonic acid from platelet membrane phospholipids. MDA formation was almost linear for a limited period of time (between 0 and 2 min with arachidonic acid and between 1 and 3 min with thrombin) and was concentration-dependent with saturation kinetics.

The hyperbolic curves obtained could be recast in linear plots (according to Woolf transformation S/V versus S) when arachidonic acid was used. With thrombin, in contrast, the highest concentration at which no MDA production could be detected (3 NIH u/ml) had to be subtracted from each concentration of the enzyme used to obtain Woolf plots. The apparent Km value of arachidonic acid was 0.49 ± 0.09 mM and Vmax was 1.44 ± 0.06 nmoles MDA/1.4 × 10⁹ platelets/min. The corresponding values in experiments with thrombin were 6.5 ± 1.5 NIH u/ml and 0.233 ± 0.012 nmoles MDA/1.4 × 10⁹ platelets/min.

Key words

Blood platelets - Arachidonic acid metabolism - Malondialdehyde - Thrombin - Kinetic analysis

• References

• 1 Samuelsson B, Goldyne M, Granström E, Hamberg M, Hammarström S, Malmsten C. Prostaglandins and thromboxanes. Annu Rev Biochem 1978; 47: 997-1029
• 2 Silver MJ, Bills TK, Smith JB. Platelets and prostaglandins: The key role of platelet phospholipase A₂ activity. In: Gaetano GDe, Garattini S. (eds.) Platelets: A Multidisciplinary Approach, . Raven Press, New York: 1978. pp. 213-225
• 3 Bell RL, Kennedy DA, Stanford N, Majerus PW. Diglyceride lipase: A pathway for arachidonate release from human platelets. Proc Natl Acad Sci USA 1979; 76: 3238-3241
• 4 Rittenhouse-Simmons S. Production of diglyceride from phosphatidylinositol in activated human platelets. J Clin Invest 1979; 63: 580-587
• 5 Flower RJ. Drugs which inhibit prostaglandin biosynthesis. Pharmacol Rev 1974; 26: 33-67
• 6 Roth GJ, Stanford N, Majerus PW. Acetylation of prostaglandin synthase by aspirin. Proc Natl Acad Sci USA 1975; 72: 3073-3076
• 7 Rome LH, Lands WE M. Properties of a partially-purified preparation of the prostaglandin-forming oxygenase from sheep vesicular gland. Prostaglandins 1975; 10: 813-824
• 8 Crook D, Collins AJ. Comparison of effects of aspirin and indomethacin on human platelet prostaglandin synthetase. Annu Rheum Dis 1977; 36: 459-463
• 9 Stanford N, Roth GJ, Shen TY, Majerus PW. Lack of covalent modification of prostaglandin synthetase (cyclo-oxygenase) by indomethacin. Prostaglandins 1977; 13: 669-675
• 10 Vargaftig BB. The inhibition of cyclo-oxygenase of rabbit platelets by aspirin is prevented by salicylic acid and by phenanthrolines. Eur J Pharmacol 1978; 50: 231-241
• 11 McMillan RM, MacIntyre DE, Booth A, Gordon JL. Malonaldehyde formation in intact platelets is catalysed by thromboxane synthase. Biochem J 1978; 176: 595-598
• 12 Silver MJ, Smith JB, Ingerman C, Kocsis JJ. Arachidonic acid-induced human platelet aggregation and prostaglandin formation. Prostaglandins 1973; 4: 863-875
• 13 Sturman JA, Smith MJ H. The binding of salicylate to plasma proteins in different species. J. Pharm Pharmacol 1967; 19: 621-622
• 14 De Gaetano G. Pharmacological properties of drugs inhibiting platelet aggregation. Acta Clin Belg 1975; 30: 184-189
• 15 Egan RW, Paxton J, Kuehl Jr FA. Mechanism for irreversible self-deactivation of prostaglandin synthetase. J Biol Chem 1976; 251: 7329-7335
• 16 Dormandy TL. Free-radical oxidation and antioxidants. Lancet 1978; 1: 647-650
• 17 Smith JB, Ingerman CM, Silver MJ. Malondialdehyde formation as an indicator of prostaglandin production by human platelets. J Lab Clin Med 1976; 88: 167-172
• 18 Diczfalusy U, Falardeau P, Hammarström S. Conversion of prostaglandin endoperoxides to C₁₇-hydroxy acids catalyzed by human platelet thromboxane synthase. FEBS Lett 1977; 84: 271-274
• 19 Wielosz M, Salmona M, De Gaetano G, Garattini S. Uptake of ¹⁴C-5-hydroxytryptamine by human and rat platelets and its pharmacological inhibition. A comparative kinetic analysis. Naunyn-Schmiedeberg's Arch Pharmacol 1976; 296: 59-65
• 20 Villa S, Livio M, De Gaetano G. The inhibitory effect of aspirin on platelet and vascular prostaglandins in rats cannot be completely dissociated. Br J Haematol 1979; 42: 425-431
• 21 Mahler HR, Cordes EH. Biological Chemistry, Enzyme Kinetics, . Harper & Row, New York: 1966
• 22 Watanabe Y, Soda M, Kobayashi B. Enhanced malondialdehyde formation in reserpinized rabbit blood platelets. Thromb Res 1979; 16: 24-35
• 23 Livio M, Rajtar G, Merino J, De Gaetano G. Malondialdehyde formation in rat platelet-rich plasma. II. Modification of the reaction kinetics by aspirin and indomethacin. Thromb Haemostas 1980; 44: 52-55